SCHEMBL1428415

SCHEMBL1428415

Nc1nc(N)c(C(=O)NC[C@@H](N)Cc2ccccc2)nc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCNN1A P37088 8/20 0.55
▸ ALDH1A1 P00352 4/20 0.55
▸ KDM4E B2RXH2 3/20 0.55
▸ HPGD P15428 3/20 0.55
▸ HSD17B10 Q99714 3/20 0.55
▸ GLA P06280 2/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ CYP1A2 P05177 2/20 0.55
▸ CYP2D6 P10635 2/20 0.55
▸ NFKB1 P19838 2/20 0.55
▸ THPO P40225 2/20 0.55
▸ HIF1A Q16665 2/20 0.55
▸ GAA P10253 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ FTO Q9C0B1 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ GMNN O75496 2/20 0.54
▸ PMP22 Q01453 2/20 0.54
▸ BLM P54132 1/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18748442 0.86 SCNN1A (0.53) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL17108573 0.86 SCNN1A (0.53) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL18748447 0.86 SCNN1A (0.53) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL11959313 0.84 SCNN1A (0.51) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL18760196 0.84 SCNN1A (0.51) SCNN1AALDH1A1KDM4EHPGDHSD17B10
Iodide SCHEMBL1428436 0.83 SCNN1A (0.50) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL18748444 0.82 SCNN1A (0.49) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL18748443 0.80 PLAU (0.48) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL1134633 0.80 SCNN1A (0.43) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL1134504 0.79 SCNN1A (0.46) SCNN1AALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201625-A1 Organic Comopunds NOVARTIS AG (CH) 2011-08-18 — — US disclosed
EP-2300010-A2 ORGANIC COMPOUNDS Novartis AG (CH) 2011-03-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201625-A1 Organic Comopunds OR10J3, CFTR, CLIC1 SCNN1A 52/4885ALDH1A1 2244/4885KDM4E 3963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback